ProAir HFA inhalers are no longer available because they have been discontinued, and their availability is now limited to the exhaustion of existing market inventory.
Discontinuation of ProAir HFA Inhalers
ProAir HFA inhalers are being phased out of the market. This means that once the current supply available in pharmacies and distribution channels is depleted, the inhaler will no longer be available for prescription. The primary reason for its unavailability stems from this discontinuation, leading to a finite supply.
Current Availability and Transition
- Dispensing Remaining Stock: While the product is being discontinued, pharmacies are permitted to dispense any remaining ProAir HFA inhalers they currently have in stock.
- Preferred Status Maintained: To facilitate the distribution of this existing inventory, the preferred status for ProAir HFA inhalers remains in effect. This allows pharmacies to continue dispensing their remaining supply efficiently.
- Impact on Future Prescriptions: Patients should be aware that once the overall market inventory of ProAir HFA is fully exhausted, new prescriptions for this specific inhaler cannot be filled. Patients will need to consult their healthcare providers to discuss alternative albuterol inhalers or other appropriate treatment options.
